Sign In
Buy MNTA
$52.48
+0 (+0%)
At Close: May 27, 2022
Macquarie Group Ltd. Sells 4,694 Shares of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)
10:54am, Sunday, 26'th Apr 2020
Macquarie Group Ltd. cut its holdings in shares of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) by 2.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Comm
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Insider Sells $40,878.54 in Stock
10:30am, Saturday, 25'th Apr 2020
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) insider Ian Fier sold 1,314 shares of the firm’s stock in a transaction on Wednesday, April 22nd. The stock was sold at an average price of $31.11, for a
Does Regeneron Pharmaceuticals’ Winning Streak Signal Irrational Exuberance?
10:30am, Friday, 24'th Apr 2020
Certain patents covering a biotech giant's multi-billion dollar biologic are set to expire starting this year. Does this mean an end for its stellar growth?
Affinivax Lands $120M to Take MAPS Tech Into New Vaccine Territory
06:41pm, Thursday, 23'rd Apr 2020
Affinivax has a lead program with early clinical data showing the potential to best a pharmaceutical giant’s blockbuster vaccine. The startup now has $120
Biotech Melt-Up
01:00pm, Thursday, 23'rd Apr 2020
A high daily death toll suggests a much more careful and measured reopening of the economy will be possible, not a quick-paced one. The pandemic thrusts the bio
Momenta Pharmaceuticals Announces Date of First Quarter 2020 Financial Results Conference Call and Webcast
12:00pm, Thursday, 23'rd Apr 2020
Momenta Pharmaceuticals, Inc. (MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today announced that it will re
Momenta Pharmaceuticals (NASDAQ:MNTA) versus ADMA Biologics (NASDAQ:ADMA) Head to Head Contrast
08:26am, Thursday, 23'rd Apr 2020
ADMA Biologics (NASDAQ:ADMA) and Momenta Pharmaceuticals (NASDAQ:MNTA) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) SVP Santiago Arroyo Sells 1,614 Shares of Stock
10:12am, Wednesday, 22'nd Apr 2020
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) SVP Santiago Arroyo sold 1,614 shares of the firm’s stock in a transaction that occurred on Monday, April 20th. The shares were sold at an average price o
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Insider Jo Ann Beltramello Sells 1,124 Shares
09:40am, Wednesday, 22'nd Apr 2020
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) insider Jo Ann Beltramello sold 1,124 shares of Momenta Pharmaceuticals stock in a transaction dated Monday, April 20th. The stock was sold at an average pr
Art Industry News: A Third of Los Angeles’s Art Galleries May Be Forced to Close This Year, a New Survey Says + Other Stories
01:29pm, Tuesday, 21'st Apr 2020
Plus, the Berlin Biennale is postponed and Judy Chicago and Swoon team up with Jane Fonda for an Earth Day art project.
Jo Ann Beltramello Sells 1,922 Shares of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Stock
09:34am, Sunday, 19'th Apr 2020
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) insider Jo Ann Beltramello sold 1,922 shares of Momenta Pharmaceuticals stock in a transaction dated Wednesday, April 15th. The stock was sold at an average
Nuveen Asset Management LLC Has $10.90 Million Stock Holdings in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA)
09:08am, Saturday, 18'th Apr 2020
Nuveen Asset Management LLC increased its position in shares of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) by 45.8% during the fourth quarter, according to the company in its most recent disclosure w
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Expected to Post Quarterly Sales of $4.08 Million
07:18am, Friday, 17'th Apr 2020
Equities research analysts expect that Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) will announce sales of $4.08 million for the current quarter, Zacks Investment Research reports. Five analysts have m
Momenta Pharmaceuticals (NASDAQ:MNTA) Stock Price Down 10.1% After Insider Selling
06:08am, Thursday, 16'th Apr 2020
Shares of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) fell 10.1% during trading on Wednesday following insider selling activity. The stock traded as low as $26.34 and last traded at $26.61, 988,229 sh
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) CAO Agnieszka Cieplinska Sells 921 Shares of Stock
09:04am, Wednesday, 15'th Apr 2020
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) CAO Agnieszka Cieplinska sold 921 shares of Momenta Pharmaceuticals stock in a transaction on Tuesday, April 14th. The shares were sold at an average price
